CD Projekt has sold its DRM-free PC storefront GOG to its original co-founder, Michał Kiciński, for 90.7 million Polish złoty (approx. $25.2 million). Kiciński is also co-founder of CD Projekt itself,...
Tech leaders like Sundar Pichai, Mark Zuckerberg, and Elon Musk led a workforce efficiency crusade in 2025. Jakub Porzycki/NurPhoto via Getty Images; Steve Granitz/FilmMagic The "efficiency" m...
Getty Images; Rebecca Zisser/BI The 2025 frozen job market could thaw by the time 2026 is over. Job-market experts like Claudia Sahm don't think the low-hire, low-fire state is sustainable. Hiring exp...
Netflix reportedly wants to keep movies in theaters for just 17 days after it buys Warner Bros. In a report from Deadline on the Stranger Thing Season 5 finale, which made $25 million in theaters afte...
Beyoncé performs during the Renaissance World Tour. Kevin Mazur/WireImage for Parkwood Beyoncé is worth $1 billion, according to Forbes' estimates. Much of her wealth is derived from her valuable musi...
CEOs are using AI to research topics and summarize emails. Franco Origlia/Ethan Miller/Getty Images; Alexander Drago/via REUTERS CEOs are integrating AI into their personal and professional lives. Nvi...
From left: Anthony Gutman, David Solomon, Jacqueline Arthur. Courtesy of Goldman Sachs 10 Goldman Sachs leaders shared their go-to book and podcast recommendations. Business Insider asked the CEO and ...
📋 Key Facts ✓ iRobot, Luminar, and Rad Power Bikes are very different companies ✓ These companies faced similar challenges ...
📋 Key Facts ✓ Bitcoin may end 2026 with a negative return, breaking the four-year cycle due to market maturation. ✓ Both U.S. political...
📋 Key Facts ✓ The Council of the European Union endorsed the launch of the digital euro. ✓ The digital euro is developed by the Europea...
📋 Key Facts ✓ 60% of Five Below's products are sourced from China, impacted by tariffs. ✓ Company stock rose 85% year-to-date as of...
📋 Key Facts ✓ The FDA approved the first-ever GLP-1 pill on Monday. ✓ The pill was developed by Novo Nordisk, a Danish pharmaceutical g...